Indefinite Delivery Contract 75D30123D15813
Award Date
12/31/22
Last Date to Order
2/28/24
Federal Agency
CDC Pittsburgh
Awardee
Sanofi Pasteur Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This multiple award IDV was issued by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh to procure pediatric flu vaccines for the 2023-2024 flu season. Glaxosmithkline, LLC was awarded the IDV as prime contractor. The IDV does not include any set-asides and has a potential value of $174.9 million. Orders may be placed through February 2024 to deliver pediatric flu vaccines in support of the CDC's efforts to increase vaccination rates among...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian federal agency, to Sanofi Pasteur Inc. as the prime contractor. The contract has a ceiling value of $144,427,500 and a period of performance from the award date of December 31, 2020 through February 28, 2022. The contract is for the provision of pediatric influenza vaccines, including a minimum order size of 100 doses and a maximum quantity of 50 million doses. The vaccines...
This federal contract IDV award from the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc. is for the supply of 2025-2026 pediatric flu vaccines. The $70.18M multiple award contract has a period of performance through February 2026. As the prime contractor, Sanofi Pasteur will leverage its pharmaceutical manufacturing and distribution capabilities to fulfill task orders for pediatric influenza vaccines in support of the CDC's public health mission. The contract was...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian federal agency, to Sanofi Pasteur Inc., the prime contractor. The contract has a total ceiling value of $158,256,000 and a period of performance running through February 28, 2025. The purpose of this IDC is to provide pediatric influenza vaccines to the CDC for the 2024-2025 season. Sanofi Pasteur, as a manufacturer of vaccines and pharmaceutical products, will fulfill task...
This indefinite delivery contract was awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc., a global pharmaceutical company, to provide a range of pediatric influenza vaccines. The 5-year contract, valued at up to $163,144,080, covers the period from December 31, 2024 to February 28, 2026. As the prime contractor, Sanofi Pasteur will leverage its manufacturing and distribution capabilities to fulfill task orders for seasonal and pre-pandemic influenza...
The Indefinite Delivery Contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh provides for pediatric flu vaccines for the 2023-2024 period. The multiple award contract has a potential value of $220.5 million and was awarded to Seqirus USA Inc. on December 31, 2022. The contract aims to procure pediatric flu vaccines through February 28, 2024 to support the Centers for Disease Control and Prevention's efforts in preventing the spread...
This multiple award IDV was issued by the Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh to procure adult flu vaccines for 2023-2024. Astrazeneca Pharmaceuticals LP is the prime contractor tasked with delivering vaccines under associated task orders or price lists up to a potential value of $8.5 million by February 2024. The CDC aims to prevent the spread of influenza through this IDV. As the leading public health agency, it coordinates the...
This federal contract IDV was awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc. as the prime contractor. It is an indefinite delivery, indefinite quantity (IDIQ) contract with a ceiling value of $1,681,772,750 for the procurement of up to 23 standard pediatric vaccines over a 1-year period of performance from April 1, 2022 to March 31, 2023. The vaccines will support the CDC's Immunization Awardees and Vaccine for Children (VFC) program, which provides...
This indefinite delivery contract was awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) to Sanofi Pasteur Inc. to procure a range of pediatric vaccines over a 1-year period of performance from April 1, 2024 through March 31, 2025. The $1.79 billion contract seeks to purchase between 100 doses and 13 million doses each of 27 different vaccines, including influenza, meningitis, pneumonia, and other standard...
The Centers for Disease Control and Prevention (CDC) has awarded a single award Indefinite Delivery Contract (IDC) to Sanofi Pasteur Inc. for the procurement of pediatric influenza vaccines. The contract has a ceiling value of $149,625,000 and a period of performance from the date of award through February 28, 2023. Under this IDC, Sanofi Pasteur Inc. will provide between 100 and 50 million doses of pediatric influenza vaccine, which will be delivered to CDC distribution centers in Colorado...